These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34359784)

  • 21. Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer.
    Yadav MP; Ballal S; Tripathi M; Damle NA; Sahoo RK; Seth A; Bal C
    Nucl Med Commun; 2017 Jan; 38(1):91-98. PubMed ID: 27782913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy and reproducibility of simplified QSPECT dosimetry for personalized
    Del Prete M; Arsenault F; Saighi N; Zhao W; Buteau FA; Celler A; Beauregard JM
    EJNMMI Phys; 2018 Oct; 5(1):25. PubMed ID: 30318563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The
    Scarpa L; Buxbaum S; Kendler D; Fink K; Bektic J; Gruber L; Decristoforo C; Uprimny C; Lukas P; Horninger W; Virgolini I
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):788-800. PubMed ID: 28083690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry.
    Kabasakal L; Toklu T; Yeyin N; Demirci E; Abuqbeitah M; Ocak M; Aygün A; Karayel E; Pehlivanoğlu H; Alan Selçuk N
    Mol Imaging Radionucl Ther; 2017 Jun; 26(2):62-68. PubMed ID: 28613198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomics Analysis for
    Kelk E; Ruuge P; Rohtla K; Poksi A; Kairemo K
    Life (Basel); 2021 Feb; 11(2):. PubMed ID: 33671761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions.
    Wang J; Zang J; Wang H; Liu Q; Li F; Lin Y; Huo L; Jacobson O; Niu G; Fan X; Zhu Z; Chen X
    Clin Nucl Med; 2019 Jun; 44(6):431-438. PubMed ID: 30985422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma.
    Khawar A; Eppard E; Sinnes JP; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
    Clin Nucl Med; 2018 May; 43(5):323-330. PubMed ID: 29485430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lacrimal Glands May Represent Organs at Risk for Radionuclide Therapy of Prostate Cancer with [(177)Lu]DKFZ-PSMA-617.
    Hohberg M; Eschner W; Schmidt M; Dietlein M; Kobe C; Fischer T; Drzezga A; Wild M
    Mol Imaging Biol; 2016 Jun; 18(3):437-45. PubMed ID: 26920354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical dosimetric studies of
    Meléndez-Alafort L; Ferro-Flores G; Santos-Cuevas C; Ocampo-García B; Turato S; Fracasso G; Bolzati C; Rosato A; De Nardo L
    Med Phys; 2021 Jul; 48(7):4064-4074. PubMed ID: 33966284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of image-based lesion and kidney dosimetry protocols for
    Resch S; Takayama Fouladgar S; Zacherl M; Sheikh GT; Liubchenko G; Rumiantcev M; Unterrainer LM; Wenter V; Bartenstein P; Ziegler SI; Ilhan H; Beyer L; Böning G; Delker A
    EJNMMI Phys; 2023 Feb; 10(1):11. PubMed ID: 36757516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.
    Baum RP; Kulkarni HR; Schuchardt C; Singh A; Wirtz M; Wiessalla S; Schottelius M; Mueller D; Klette I; Wester HJ
    J Nucl Med; 2016 Jul; 57(7):1006-13. PubMed ID: 26795286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of simplifying renal dosimetry in
    Sundlöv A; Gustafsson J; Brolin G; Mortensen N; Hermann R; Bernhardt P; Svensson J; Ljungberg M; Tennvall J; Sjögreen Gleisner K
    EJNMMI Phys; 2018 Jul; 5(1):12. PubMed ID: 29974391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of
    Belli ML; Sarnelli A; Mezzenga E; Cesarini F; Caroli P; Di Iorio V; Strigari L; Cremonesi M; Romeo A; Nicolini S; Matteucci F; Severi S; Paganelli G
    Front Oncol; 2020; 10():531660. PubMed ID: 33251129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617.
    Kratochwil C; Giesel FL; Stefanova M; Benešová M; Bronzel M; Afshar-Oromieh A; Mier W; Eder M; Kopka K; Haberkorn U
    J Nucl Med; 2016 Aug; 57(8):1170-6. PubMed ID: 26985056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies.
    Hou X; Brosch J; Uribe C; Desy A; Böning G; Beauregard JM; Celler A; Rahmim A
    J Nucl Med; 2021 Jul; 62(7):1006-1011. PubMed ID: 33127625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of sampling schedules on [
    Rinscheid A; Kletting P; Eiber M; Beer AJ; Glatting G
    EJNMMI Phys; 2020 Jun; 7(1):41. PubMed ID: 32556844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single-institution experience with
    George SC; Tolakanahalli R; Aguirre S; Kim TP; Samuel EJJ; Mishra V
    Front Oncol; 2024; 14():1331266. PubMed ID: 38469241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simplified dosimetry for kidneys and tumors in
    Ardenfors O; Nilsson JN; Thor D; Hindorf C
    EJNMMI Phys; 2022 Jun; 9(1):44. PubMed ID: 35723797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and accuracy of single time point imaging for renal dosimetry following
    Willowson KP; Eslick E; Ryu H; Poon A; Bernard EJ; Bailey DL
    EJNMMI Phys; 2018 Dec; 5(1):33. PubMed ID: 30569328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Translation and First In-Human Use of [
    Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
    Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.